ARS Pharmaceuticals Inc XNAS: SPRY

Expensive Underperformer

Download real time

9.92 0.13 (1.33%)

47.51% Fall from 52W High

742.5K

XNAS Volume

XNAS 10 Feb, 2026 4:30 PM (EST)

ARS Pharma Inc quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents